Ribosome-inactivated CRC cells survived more from chemotherapeutic treatment via PRDM1-IGF-mediated regulation of non-canonical Wnt-linked cancer cell stemness, all of which provided mechanistic evidence of chemoresistance of CRC. This evidence concerns the gene PRDM1 and colorectal carcinoma.